Skip to main content

Table 1 Demographic, clinical, and CPB data of trial groups

From: Influence of hypothermia on right atrial cardiomyocyte apoptosis in patients undergoing aortic valve replacement

  ModHT Group (n = 10) MiHT Group (n = 10) p Value
Age (y) 70.6 ± 9.7 67.7 ± 12.3 0.565
Female, n (%) 4 (40%) 4 (40%) 1.000
Hypertension, n (%) 6 (60%) 6 (60%) 1.000
Smoking history, n (%) 4 (40% 2 (20%) 0.626
Diabetes, n (%) 2 (20%) 1 (10%) 1.000
Hyperlipidemia, n (%) 4 (40%) 2 (20%) 0.626
Atrial fibrillation, n (%) 2 (20%) 4 (40%) 0.626
LVEF (%) 62.2 ± 17.1 57.8 ± 17.8 0.580
CPB time (min) 85.2 ± 11.3 87.5 ± 21.1 0.765
Aortic crossclamping time (min) 59.2 ± 7.8 59.0 ± 16.6 0.973
Minimal core CPB temperature (nasopharyngeal) (°C) 28.2 ± 1.1 34.5 ± 0.9 < 0.001
Need for postCPB inotropic support, n (%) 2 (20%) 2 (20%) 1.000
  1. Results are expressed as means ± standard deviations, unless otherwise indicated.
  2. CPB, cardiopulmonary bypass; LVEF, left ventricular ejection fraction.